Julia A. Leeman
Known title: SVP - Campus OperationsCIK: 0002047690
Associated companies
Transaction History
| PRDO | ▼ Sell | Open Market | 11,315 | $402K | 5/12/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 591 | $21K | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 468 | $17K | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 3,334 | $119K | 3/14/2026 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 3,832 | $0 | 3/14/2026 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 297 | $11K | 3/14/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 2,652 | $0 | 3/10/2026 | View on chart |
| PRDO | ▲ Buy | Grant | 1,768 | $0 | 3/10/2026 | View on chart |
| PRDO | ▼ Sell | Open Market | 5,000 | $160K | 5/28/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 454 | $11K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 418 | $10K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 337 | $8K | 3/14/2025 | View on chart |
| PRDO | ▼ Sell | Tax Withholding | 2,987 | $73K | 3/14/2025 | View on chart |
| PRDO | ▲ Buy | Option Exercise | 5,140 | $0 | 3/14/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 3,058 | $0 | 3/6/2025 | View on chart |
| PRDO | ▲ Buy | Grant | 2,039 | $0 | 3/6/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 24, 2026
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline
Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.
Perdoceo Education (PRDO) Focuses on Healthcare Expansion and Cost Discipline. Recent analysis highlights Perdoceo's expansion into healthcare education as a potential value driver. Commentators note that growth in the USAHS segment and strict cost management support a positive outlook for the company. These strategic moves are being watched closely by investors evaluating the stock's long-term positioning.